Intravenous immunoglobulin as clinical immune-modulating therapy

Laurent Gilardin; Jagadeesh Bayry; Srini V. Kaveri

doi:10.1503/cmaj.130375

Review

Intravenous immunoglobulin as clinical immune-modulating therapy

Laurent Gilardin, Jagadeesh Bayry and Srini V. Kaveri

CMAJ March 03, 2015 187 (4) 257-264; DOI: https://doi.org/10.1503/cmaj.130375

Laurent Gilardin

Unité 872, Institut national de la santé et de la recherche médicale, and Équipe 16: Immunopathologie et immuno-intervention thérapeutique, Centre de recherche des Cordeliers, Université Pierre et Marie Curie and Université Paris Descartes, Paris, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jagadeesh Bayry

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Srini V. Kaveri

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: srini.kaveri@crc.jussieu.fr

Article
Figures & Tables
Related Content
Responses
Metrics
PDF

Data supplements

Online Appendices

Files in this Data Supplement:

Appendix 1: Official guidelines for intravenous immunoglobulin use
Appendix 2: Classification of evidence levels
Earn CME Credits

This article is eligible for 0.5 Mainpro credits.

Did you read this article?

More information

Note: The YES link above may not work in certain versions of Internet Explorer 8. If you are having difficulties with this link, please try another browser.

(2015). Highlights. CMAJ, 187(4), 231. Accessed September 24, 2020. Retrieved from http://www.cmaj.ca/content/187/4/231.

PubMed
Google Scholar

PreviousNext

In this issue

Canadian Medical Association Journal: 187 (4)

CMAJ

Vol. 187, Issue 4

3 Mar 2015

Table of Contents
Index by author

Article tools

Respond to this article

Download PDF

Article Alerts

User Name *

Password *

To sign up for email alerts or to access your current email alerts, enter your email address below:

Email *

Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Intravenous immunoglobulin as clinical immune-modulating therapy

Message Subject (Your Name) has sent you a message from CMAJ

Message Body (Your Name) thought you would like to see the CMAJ web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Intravenous immunoglobulin as clinical immune-modulating therapy

Laurent Gilardin, Jagadeesh Bayry, Srini V. Kaveri

CMAJ Mar 2015, 187 (4) 257-264; DOI: 10.1503/cmaj.130375

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Request Permissions

Intravenous immunoglobulin as clinical immune-modulating therapy

Laurent Gilardin, Jagadeesh Bayry, Srini V. Kaveri

CMAJ Mar 2015, 187 (4) 257-264; DOI: 10.1503/cmaj.130375

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Tables
Related Content
Responses
Metrics
PDF

Highlights

PubMed
Google Scholar

Cited By...

Passive Serum Therapy to Immunomodulation by IVIG: A Fascinating Journey of Antibodies
ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis

Google Scholar

Collections

Topics

Main menu

User menu

Search

Intravenous immunoglobulin as clinical immune-modulating therapy

Data supplements

Online Appendices

Earn CME Credits

In this issue

Article tools

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Collections

Content

Information for

About